Polycystic ovary syndrome: clinical aspects (Q41084868)

26 September 2017

1 reference

title

Polycystic ovary syndrome: clinical aspects (English)

1 reference

polycystic ovary syndrome

26 September 2017

1 reference

1 reference

Conway GS

1

1 reference

26 September 2017

1 April 1996

1 reference

Bailliere's clinical endocrinology and metabolism

26 September 2017

1 reference

26 September 2017

10

1 reference

26 September 2017

2

1 reference

26 September 2017

263-279

1 reference

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Clinical review 56: Nonclassic adrenal hyperplasia: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Clinical implications of hyperinsulinaemia in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The role of ovarian proteases and their inhibitors in ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The androgenicity of progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Bone mineral loss in young women with amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Does testosterone affect the normal menstrual cycle?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Comparison of the efficacy of spironolactone**Spironolactone (Aldactone; Searle, Chicago, IL). versus flutamide††Flutamide (Eulexin; Schering Plough Laboratories, Heist, Belgium). in the treatment of hirsutism‡‡Presented in part at the 3rd Wo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The polycystic ovary. I. Clinical and histologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The treatment of women with hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Idiopathic Hirsutism — An Ovarian Abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Polycystic ovary syndrome and bulimia**Supported by the Special Trustees of St. George’s Hospital and the Priory Hospital, London, United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Androgens and human hair growth

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Clinical features of young women with hypergonadotropic amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

1 reference

7 January 2021

Spironolactone in dermatologic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Ultrasonic assessment of the endometrium as a predictor of oestrogen status in amenorrhoeic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Ketoconazole therapy for women with acne and/or hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Hepatotoxicity complicating flutamide treatment of hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

Connective tissue breakdown in ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

The polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980113-3

7 January 2021

10.1016/S0950-351X(96)80113-3

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8773748